FDA Inspection 1200695 — ADMA BioCenters Georgia Inc
The FDA completed an inspection of ADMA BioCenters Georgia Inc on Feb 3, 2023 in Goose Creek, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 3, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Goose Creek, SC (United States)